共 145 条
[1]
Umakanthan S(2020)Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19) Postgrad Med J 96 753-758
[2]
Sahu P(2020)Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Lancet 395 1054-1062
[3]
Ranade AV(2020)Acute pulmonary embolism in COVID-19 disease: preliminary report on seven patients Int J Cardiol 313 129-131
[4]
Bukelo MM(2020)Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China Ann Oncol 31 894-901
[5]
Rao JS(2020)The pathology of severe COVID-19-related lung damage Dtsch Arztebl Int 117 500-506
[6]
Abrahao-Machado LF(2021)Severity of COVID-19 in patients with lung cancer: evidence and challenges J Immunother Cancer 9 e002266-791
[7]
Zhou F(2020)Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak Cancer Discov 10 783-2092
[8]
Yu T(2018)Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer N Engl J Med 378 2078-895
[9]
Du R(2021)Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189 Ann Oncol 32 881-1550
[10]
Fan G(2016)Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial Lancet 387 1540-2051